Main content of this page

Anchor links to the different areas of information in this page:

You are here: MEDICA Portal. MEDICA Magazine. Alzheimer's.

Public Health & Associations

Public Health & Associations

News on public health research and national as well as international health policies. Edited by MEDICA.de and several associations.

 
 

Diabetes Drug: Could Help Fight Alzheimer's Disease?

( Source: MEDICA.de )

[17/09/2012] A drug designed for diabetes sufferers could have the potential to treat neurodegenerative diseases like Alzheimer’s, a study by scientists at the University of Ulster has revealed. Type II diabetes is a known risk factor for Alzheimer’s and it is thought that impaired insulin signalling in the brain could damage nerve cells and contribute to the disease.Diabetes Drug: Could Help Fight Alzheimer's Disease? - Read more

Alzheimer's Patients: Delirium and Long-term Cognitive Decline

( Source: MEDICA.de )

[21/08/2012] Patients with Alzheimer's disease who suffered episodes of delirium while hospitalized had a sharply increased rate of mental decline for up to five years after being hospitalized compared to those who did not have any such episodes, according to a study by researchers at the Institute for Aging Research at Hebrew SeniorLife.Alzheimer's Patients: Delirium and Long-term Cognitive Decline - Read more

Dementia: Autoantibodies Damage Blood Vessels in The Brain

( Source: MEDICA.de )

[01/08/2012] The presence of specific autoantibodies of the immune system is associated with blood vessel damage in the brain. These findings were made by researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin, Germany, in studies on a rat model.Dementia: Autoantibodies Damage Blood Vessels in The Brain - Read more

Drugs Ferry: ”We are not limited to one active ingredient group or one active ingredient“

( Source: MEDICA.de )

[08/05/2012] Drugs that treat brain diseases such as Alzheimer’s disease or multiple sclerosis are most effective directly where they are needed – in the brain. Unfortunately, it is difficult to develop drugs that are capable of getting there specifically, since the so-called blood-brain barrier prevents this from happening. However, now a team led by Doctor Heiko Manninga succeeded in doing precisely that. Drugs Ferry: ”We are not limited to one active ingredient group or one active ingredient“ - Read more

Brain: New Understanding of Alzheimer's Trigger

( Source: MEDICA.de )

[07/05/2012] A highly toxic beta-amyloid – a protein that exists in the brains of Alzheimer's disease victims – has been found to greatly increase the toxicity of other more common and less toxic beta-amyloids, serving as a possible "trigger" for the advent and development of Alzheimer's, researchers at the University of Virginia have discovered.Brain: New Understanding of Alzheimer's Trigger - Read more

 
 
 
© Messe Düsseldorf printed by www.MEDICA.de